Insider · CIK 0001337845

Sinha Vikas

Reports to the SEC for 5 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001337845

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-16	SRRKScholar Rock Holding CorpS Sale	Chief Financial Officer	SSale	−10.4K sh	$49.57	−$516K	619,856
2026-02-09	SRRKScholar Rock Holding CorpA Award	Chief Financial Officer	AAward	+47K sh	—	—	630,266
2026-01-13	SRRKScholar Rock Holding CorpS Sale	Chief Financial Officer	SSale	−16.8K sh	$42.70	−$715K	583,245
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−96K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−64K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−94.1K sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Restricted Share UnitM Exercise/Conversion	Director	MExercise/Conversion	−72K sh	—	—	0
2025-10-07	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+72K sh	—	—	72,000
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−384 sh	—	—	0
2025-10-07	VRNAVerona Pharma plc · Share Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−240K sh	—	—	0
2025-08-01	VRNAVerona Pharma plcS Sale	Director	SSale	−4,328 sh	$13.14	−$56.9K	94,112
2025-08-01	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+24K sh	—	—	98,440
2025-08-01	VRNAVerona Pharma plc · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−24K sh	—	—	72,000
2025-05-20	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+160K sh	$0.50	+$80.6K	234,440
2025-05-20	VRNAVerona Pharma plcS Sale	Director	SSale	−160K sh	$9.39	−$1.5M	74,440
2025-05-20	VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−160K sh	—	—	384
2025-05-02	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+110K sh	—	—	110,067
2025-04-29	VRNAVerona Pharma plcS Sale	Director	SSale	−4,952 sh	$8.92	−$44.2K	74,440
2025-04-29	VRNAVerona Pharma plcS Sale	Director	SSale	−15K sh	$8.92	−$134K	74,440
2025-04-29	VRNAVerona Pharma plcS Sale	Director	SSale	−39.6K sh	$8.92	−$353K	74,440
2025-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−39.6K sh	—	—	160,384
2025-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−120K sh	—	—	0
2025-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	80,952
2025-04-29	VRNAVerona Pharma plcS Sale	Director	SSale	−120K sh	$8.92	−$1.07M	74,440
2025-04-29	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$1.70	+$25.6K	89,488
2025-04-29	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+39.6K sh	$0.50	+$20K	114,056
2025-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,952 sh	—	—	195,048
2025-04-29	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+120K sh	$1.70	+$205K	194,824
2025-04-29	VRNAVerona Pharma plcM Exercise/Conversion	Director	MExercise/Conversion	+4,952 sh	$0.50	+$2,494.818	79,392
2025-04-27	SRRKScholar Rock Holding CorpA Award	Chief Financial Officer	AAward	+500K sh	—	—	600,000
2025-04-27	SRRKScholar Rock Holding CorpA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2025-04-25	VRNAVerona Pharma plc · Restricted Share UnitsA Award	Director	AAward	+96K sh	—	—	96,000
2025-02-21	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−303 sh	$10.08	−$3,052.967	49,129
2025-01-23	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−116 sh	$9.45	−$1,096.641	49,445
2025-01-23	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−13 sh	$9.94	−$129.223	49,432
2025-01-10	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−979 sh	$0.44	−$430.858	1,139,915
2024-11-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−3,186 sh	$0.55	−$1,747.521	1,140,894
2024-11-05	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−5,136 sh	$0.86	−$4,442.126	1,144,080
2024-10-22	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−1,882 sh	$0.77	−$1,445	1,149,216
2024-10-21	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−1,546 sh	$0.78	−$1,204.334	1,151,098
2024-10-03	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−940 sh	$0.81	−$765.912	1,152,644
2024-08-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−3,159 sh	$0.76	−$2,399.261	1,153,584
2024-08-05	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−5,251 sh	$0.73	−$3,858.435	1,156,743
2024-07-22	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−1,858 sh	$0.74	−$1,373.434	1,161,994
2024-07-19	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−1,542 sh	$0.75	−$1,156.654	1,163,852
2024-07-02	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−939 sh	$0.72	−$676.08	1,165,394
2024-05-17	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−3,143 sh	$0.75	−$2,355.05	1,129,996
2024-05-03	KLRSKalaris Therapeutics, Inc.S Sale	Director, See Remarks, 10% Owner	SSale	−4,957 sh	$0.80	−$3,945.772	1,133,139
2024-04-29	VRNAVerona Pharma plc · Share Options (Right to Buy)A Award	Director	AAward	+240K sh	—	—	240,000

Recent filings

Accepted (ET)
Apr 204
Sinha Vikas0001104659-26-045582
SEC(opens sec.gov)
Feb 114
Sinha Vikas0001104659-26-013586
SEC(opens sec.gov)
Jan 154
Sinha Vikas0001104659-26-004224
SEC(opens sec.gov)
Oct 84
Sinha Vikas0001104659-25-097954
SEC(opens sec.gov)
Aug 54
Sinha Vikas0001104659-25-074382
SEC(opens sec.gov)
May 224/A
Sinha Vikas0001104659-25-051979
SEC(opens sec.gov)
May 224
Sinha Vikas0001104659-25-051986
SEC(opens sec.gov)

Companies

Address

301 BINNEY STREET

CAMBRIDGE, MA, 02142